Richard Bryan Bell MD MD, DDS, FACS, FRCS(Ed)

Summary

• R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed), is the Executive Medical Director of Providence Cancer Institute of Oregon, Director and Member of Earle A. Chiles Research Institute, and holds the Walter J. Urba Chair for Cancer Research in Portland, Oregon. In these roles, he oversees oncology services and research teams that deliver care to more than 6,000 cancer patients annually in 32 clinics and eight Oregon hospitals.
  
  As an internationally recognized head and neck surgeon, Dr. Bell has led pioneering research and clinical efforts to integrate immunotherapy into the neoadjuvant setting. Using his surgical practice to conduct clinical trials, Dr. Bell’s research bridges basic, translational and clinical activities. In addition, he has worked to develop technologically advanced methods to enhance the effectiveness of head and neck cancer surgery, including virtual surgical planning, transoral robotic surgery and sentinel lymph node biopsy. Dr. Bell’s work has been published in more than 350 scientific articles and book chapters, and he is co-author of two major textbooks, including "Oral, Head and Neck Oncology and Reconstructive Surgery".
  
  For almost three decades, Dr. Bell has been active in educating the next generation of surgeons. He has trained or mentored dozens of surgical residents, fellows and students in head and neck oncologic and reconstructive surgery. Dr. Bell has served on National Institutes of Health Head and Neck Steering Committee’s Immunotherapy Clinical Trials Planning Group and the Task Force on Previously Untreated/Locally Advanced (PULA) Disease. In addition, he has held numerous leadership positions and board appointments within various professional and non-profit organizations. Amongst his honors, Dr. Bell has been awarded Fellowship in the Royal College of Surgeons of Edinburgh, Ad Hominem.